Meet Our Experts

Alexander Krannich

Dr. Alexander Krannich provides expert biostatistics and clinical study support services for pharmaceutical, medical device, biotech and digital health (DiGA) clients. He handles study planning, statistical analysis, and reporting to meet regulatory requirements (e.g., EMA, FDA, BfArM). Their services include study design, sample size calculation, endpoint definition, data analysis, and support throughout the entire clinical research process. They also offer Real-World Evidence analysis and training through the BioStats Academy.

Jörg Täubel

Expert for cardiac safety in drug development

Katja Wosikowski

Expert for Nonclinical Drug Development

• Preclinical pharmacology, safety pharmacology, immunology, toxicology, pharmacokinetics and BA method development
• Translation to early clinical studies including of PK, ADA and Biomarker analysis
• Documents for CTA and IND

Daniel Sehrt

Expert for Early Clinical Research & Development

• Scientific concept & design of Phase I-IIa trials
• Clinical pharmacology (PK/PD and pharmacogenomics)
• Clinical trial applications

Frank S. Zollmann

Expert for Pre-/ Clinical Drug Development

• Safety pharmacology, toxicology, pharmacogenomics
• Integrated preclinical & clinical development up to PoC
• Clinical pharmacology

Astrid Schott

Expert for Clinical Research & Development

• Clinical Development planning, Phase I-III
• Interim management
• Due Diligence, licensing

Sabine Pilari

Expert for Pharmacometrics and PK/PD Modeling

• PK and PK/PD analyses, including exposure-response, mechanistic, and PBPK modeling
• Human PK prediction and estimation of efficacious & starting doses
• Pharmacometrics analysis, population PK, and PK/PD modeling
• Guidance on dose selection and dosing regimen optimization for clinical studies